Default company panoramic image

SamanTree Technologies AG

Digital microscopy company, with the mission to enable in-vivo histology for tumor resection guidance and early-stage tumor diagnosis.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Lausanne, Switzerland
  • Currency CHF
  • Founded February 2013
  • Employees 5
  • Website

Company Summary

Enabling in-vivo histology for precise cancer surgery, and automation of industrial microscopy for high-throughput diagnostic imaging are examples of the application of SamanTree's patented, micro-optics based, digital microscopy systems. In order to exploit the full potential of our microscopy platform technology and create revenues early on, we engage in product co-developments with established market leaders, in the target markets.


  • Default avatar
    Etienne Shaffer
    Cofounder & Head of HistoScope R&D

    Etienne has joined SamanTree in 2012 and is the project leader for developing SamanTree’s bench-top microscopy technology into a hand-held, clinical endomicroscopy prototype. Etienne holds a PhD in photonics (multiphoton microscopy) and has a proven track record in assembling advanced microscopes.

  • Default avatar
    Bastien Rachet
    Founding CTO

    Since early 2010 Bastien is actively working on the development of SamanTree’s core technology, which inspired the common vision with Davor for SamanTree. He joined the EPFL in 2007, where he acted as one of the co-inventors of the large-field microscopy technique. Working since 2003 in the R&D environment, Bastien has specialized in applied optics for fluorescence microscopy. He owns a PhD in Biophotonics.

  • Default avatar
    Davor Kosanic
    Founding CEO

    Davor has been growing SamanTree since mid-2010. Supported initially by a KPMG Inspiration Grant, and a Gebert Rüf Pilot Project Grant, he raised a seed investment (500K CHF) from the Zurcher Kantonalbank and obtained a multi-partner grant from the Swiss CTI, Davor has secured the necessary financing for the initial development of the SamanTree venture. Davor owns a PhD in Life Sciences.

  • Default avatar
    Oengus Ramsay
    CFO ad interim

    Oengus is an experienced Financial Director, with over 25 years of work experience. Particularly with the recent work experiences at Debiopharm, and consulting start-up companies, he brings the necessary senior experience into the company, particularly for strategic financial planning and negotiating of co-development and licensing agreements. Oengus owns an accounting degree from University College Dublin and a MBA from INSEAD, Fontainebleau.


  • Default avatar
    Jacques Bonvin, Tavernier Tschanz - Geneva
    Default avatar
    Rebecca Widmer - Findea AG

Previous Investors

  • Default avatar
    Zürcher Kantonalbank (ZKB)